Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1995 1
1996 1
1997 2
1998 2
1999 1
2000 2
2001 3
2002 3
2003 2
2004 2
2005 1
2006 2
2007 2
2009 2
2010 2
2011 3
2012 2
2013 6
2014 4
2015 8
2016 9
2017 12
2018 16
2019 10
2020 19
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32527945

105 results
Results by year
Filters applied: . Clear all
Page 1
Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan.
Bargagli M, Dhayat NA, Anderegg M, Semmo M, Huynh-Do U, Vogt B, Ferraro PM, Fuster DG. Bargagli M, et al. Clin J Am Soc Nephrol. 2020 Jul 1;15(7):1007-1014. doi: 10.2215/CJN.13861119. Epub 2020 Jun 11. Clin J Am Soc Nephrol. 2020. PMID: 32527945
Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
Boertien WE, Meijer E, de Jong PE, ter Horst GJ, Renken RJ, van der Jagt EJ, Kappert P, Ouyang J, Engels GE, van Oeveren W, Struck J, Czerwiec FS, Oberdhan D, Krasa HB, Gansevoort RT. Boertien WE, et al. Am J Kidney Dis. 2015 Jun;65(6):833-41. doi: 10.1053/j.ajkd.2014.11.010. Epub 2015 Jan 15. Am J Kidney Dis. 2015. PMID: 25600953
Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial.
Torres VE, Higashihara E, Devuyst O, Chapman AB, Gansevoort RT, Grantham JJ, Perrone RD, Ouyang J, Blais JD, Czerwiec FS; TEMPO 3:4 Trial Investigators. Torres VE, et al. Clin J Am Soc Nephrol. 2016 May 6;11(5):803-11. doi: 10.2215/CJN.06300615. Epub 2016 Feb 23. Clin J Am Soc Nephrol. 2016. PMID: 26912543 Free PMC article. Clinical Trial.
Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease.
Edwards ME, Chebib FT, Irazabal MV, Ofstie TG, Bungum LA, Metzger AJ, Senum SR, Hogan MC, El-Zoghby ZM, Kline TL, Harris PC, Czerwiec FS, Torres VE. Edwards ME, et al. Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1153-1161. doi: 10.2215/CJN.01520218. Epub 2018 Jul 19. Clin J Am Soc Nephrol. 2018. PMID: 30026287 Free PMC article. Clinical Trial.
Body size and 24-hour urine composition.
Taylor EN, Curhan GC. Taylor EN, et al. Am J Kidney Dis. 2006 Dec;48(6):905-15. doi: 10.1053/j.ajkd.2006.09.004. Am J Kidney Dis. 2006. PMID: 17162145
Sodium and urea excretion as determinants of urine output in autosomal dominant polycystic kidney disease patients on V2 receptor antagonists: impact of dietary intervention.
Côté G, Asselin-Thompstone L, Mac-Way F, René de Cotret P, Lacroix C, Desmeules S, Agharazii M. Côté G, et al. Int Urol Nephrol. 2020 Feb;52(2):343-349. doi: 10.1007/s11255-020-02384-3. Epub 2020 Feb 1. Int Urol Nephrol. 2020. PMID: 32008201
Determinants of Urine Volume in ADPKD Patients Using the Vasopressin V2 Receptor Antagonist Tolvaptan.
Kramers BJ, van Gastel MDA, Boertien WE, Meijer E, Gansevoort RT. Kramers BJ, et al. Am J Kidney Dis. 2019 Mar;73(3):354-362. doi: 10.1053/j.ajkd.2018.09.016. Epub 2018 Dec 19. Am J Kidney Dis. 2019. PMID: 30578153 Clinical Trial.
Short-Term Tolvaptan Increases Water Intake and Effectively Decreases Urinary Calcium Oxalate, Calcium Phosphate and Uric Acid Supersaturations.
Cheungpasitporn W, Erickson SB, Rule AD, Enders F, Lieske JC. Cheungpasitporn W, et al. J Urol. 2016 May;195(5):1476-1481. doi: 10.1016/j.juro.2015.11.027. Epub 2015 Nov 17. J Urol. 2016. PMID: 26598423 Free PMC article. Clinical Trial.
[Sodium excretion in children with lithogenic disorders].
Kovacević L, Kovacević S, Smoljanić Z, Peco-Antić A, Kostić N, Gajić M, Kovacević N, Jovanović O. Kovacević L, et al. Srp Arh Celok Lek. 1998 Sep-Oct;126(9-10):321-6. Srp Arh Celok Lek. 1998. PMID: 9863402 Serbian.
Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial.
Gansevoort RT, Meijer E, Chapman AB, Czerwiec FS, Devuyst O, Grantham JJ, Higashihara E, Krasa HB, Ouyang J, Perrone RD, Torres VE; TEMPO 3:4 Investigators. Gansevoort RT, et al. Nephrol Dial Transplant. 2016 Nov;31(11):1887-1894. doi: 10.1093/ndt/gfv422. Epub 2015 Dec 17. Nephrol Dial Transplant. 2016. PMID: 26681730 Free PMC article. Clinical Trial.
105 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback